Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia

• Tomohiro Yamasaki,

  Affiliation Division of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan

  ⨯
• Yoshio Iwashima ,

  * E-mail: iwashima@hsp.ncvc.go.jp

  Affiliation Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan

  ⨯
• Subrina Jesmin,

  Affiliation Faculty of Medicine, University of Tsukuba, Tsukuba City, Ibaragi, Japan

  ⨯
• Yuko Ohta,

  Affiliation Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan

  ⨯
• Hiroshi Kusunoki,

  Affiliation Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan

  ⨯
• Shin-ichiro Hayashi,

  Affiliation Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan

  ⨯
• Takeshi Horio,

  Affiliation Department of General Internal Medicine 3, Kawasaki Medical School, Okayama City, Okayama, Japan

  ⨯
• Yuhei Kawano

  Affiliation Division of Hypertension and Nephrology, National Cerebral and Cardiovascular Center, Suita City, Osaka, Japan

  ⨯